← Back to headlines
Regeneron Receives Approval for Every 20-Week Dosing of Eylea HD
Pharmaceutical company Regeneron has gained approval for an extended 20-week dosing regimen for its drug Eylea HD.
2 Apr, 17:27 — 2 Apr, 17:27
Sources
Showing 1 of 1 sources
